A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

BACKGROUND: We describe a randomized, non-blinded Phase II interventional study to assess the safety and efficacy of stereotactic ablative radiotherapy (SABR) for hormone-sensitive oligometastatic prostate adenocarcinoma, and to describe the biology of the oligometastatic state using immunologic, ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Radwan, Noura, Phillips, Ryan, Ross, Ashley, Rowe, Steven P., Gorin, Michael A., Antonarakis, Emmanuel S., Deville, Curtiland, Greco, Stephen, Denmeade, Samuel, Paller, Channing, Song, Daniel Y., Diehn, Maximilian, Wang, Hao, Carducci, Michael, Pienta, Kenneth J., Pomper, Martin G., DeWeese, Theodore L., Dicker, Adam, Eisenberger, Mario, Tran, Phuoc T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492934/
https://www.ncbi.nlm.nih.gov/pubmed/28662647
http://dx.doi.org/10.1186/s12885-017-3455-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492934/
https://www.ncbi.nlm.nih.gov/pubmed/28662647
http://dx.doi.org/10.1186/s12885-017-3455-6

Ejemplares similares